Navigation Links
CSUCI Receives $1.7 Million Grant for Stem Cell Research Program
Date:3/25/2009

CAMARILLO, Calif., March 25 /PRNewswire/ -- Dr. Ching-Hua Wang, Chair of Biology, Geology and Nursing, and Director of the MS Biotechnology and Bioinformatics Program at California State University Channel Islands, was recently awarded a grant of $1,733,406 from the California Institute for Regenerative Medicine (CIRM) as a part of their Bridges to Stem Cell Research program. CSUCI was one of 11 universities statewide to receive funding from the program.

"We are thrilled to have been awarded one of the CIRM grants. These grants are critically important to the future of regenerative medicine in California. Without personnel trained to carry out this research, the stem cell research field would not move as quickly as we would like," stated Dr. Wang.

The grant will fund both comprehensive lecture and laboratory courses designed to train students in stem cell research, internship placement, and completion of a new Emphasis in Stem Cell Technology and Laboratory Management within the MS Biotechnology and Bioinformatics degree program at CSUCI. The new degree program will provide students with the necessary expertise to enter the workforce in a rapidly expanding and technologically advanced field. One of the courses funded by the grant is a general education course on stem cell technology to be developed by faculty at CSUCI in collaboration with faculty from community colleges in Ventura County.

Robert Klein, chairman of the CIRM governing board stated, "Training young people is critical to our mission of developing new therapies. As California's stem cell industry continues to grow, the state will face a critical shortage for biomedical laboratory workers trained in state-of-the-art techniques required by stem cell research labs." Klein goes on to say that the Bridges to Stem Cell Research program trains students to fill these necessary positions in the industry.

CIRM was established in 2005 with the passage of the California Stem Cell Research and Cures Act. The mission of CIRM is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury. The CIRM governing board has approved more than $693 million in grants, making it the largest source of funding for embryonic stem cell research in the world.

For further information about the CIRM grant or the MS Biotechnology and Bioinformatics degree program at CSUCI, contact Dr. Ching-Hua Wang at 805-437-8870 or ching-hua.wang@csuci.edu.

For media inquiries contact Nancy Covarrubias Gill, Director of Communication & Marketing at CSUCI, 805-437-8456 or nancy.gill@csuci.edu.

CSU Channel Islands is accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges.

CSUCI Mission Statement

Placing students at the center of the educational experience, California State University Channel Islands provides undergraduate and graduate education that facilitates learning within and across disciplines through integrative approaches, emphasizes experiential and service learning, and graduates students with multicultural and international perspectives.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Ching-Hua Wang

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87147


'/>"/>
SOURCE CSU Channel Islands
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Shark Finds and Kevin Harrington, along with the ... campaign with Belly Bands. , Having a dog is great—except when it wets every ... find nothing works, get Belly Bands, the easiest way to stop dogs from ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Love is in ... in a variety of colors, assortments and packaging. This staple for Valentine’s Day is ... Kullen location. , For Valentine’s Day, not only are long-stem roses available, but ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... stage for new clinical and scientific initiatives have all marked the last 12 ... appointed President and CEO of the nation’s oldest cancer center, Candace S. Johnson, ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of micro-needling services in their Napa Valley office. The technique utilizes the body’s ... Associates, Dr. Canales and Dr. Furnas, are part of only a select few ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active ... Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division ... completed his first three-year term as chief and began a second three-year term in ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Wegener Polyangiitis ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline Review, ... Polyangiitis,s therapeutic pipeline. This report provides comprehensive ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... SILVER SPRING, Md. , Feb. 4, 2016 ... Robert Califf , the FDA,s Deputy Commissioner for Medical Products ... far-reaching action plan to reassess the agency,s approach to opioid ... the epidemic, while still providing patients in pain access to ... The FDA will: , Re-examine the risk-benefit ...
Breaking Medicine Technology: